We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Tiny Swallowable Vibrating Capsule Could Transform Clinical Approach to Disorders of Gut-Brain Interaction

By HospiMedica International staff writers
Posted on 14 Jul 2023

A pioneering study has made considerable progress in understanding the complex gut-brain nexus, a complex interplay that has long baffled researchers due to the challenges associated with probing the body's internal environment. More...

In the study, scientists at the Laureate Institute for Brain Research (LIBR, Tulsa, OK, USA) had participants ingest a minimally invasive vibrating capsule developed by Vibrant Ltd. (Newton, MA, USA). This was done to assess neural reactions during gastrointestinal stimulation, introducing a unique method to examine this intricate connection. The study's participants comprised healthy male and female volunteers aged between 18 and 40. The team found that the participants could sense the capsule's vibration under two scenarios: normal and intensified. The heightened stimulation resulted in superior perceptual accuracy, quicker identification of the stimulation, and a decrease in reaction time variability, implying the potential for further exploration of this method within various clinical cohorts. This marks a notable advancement as it validates the viability of this novel approach to studying gut feelings.

The researchers also identified the "gastric evoked potential," a delayed neural response in specific brain regions specifically triggered by the capsule's stimulation. These neural responses escalated in amplitude based on the stimulation intensity and were significantly correlated with perceptual accuracy. This finding offers a novel method to measure and understand the neural mechanisms governing the gut-brain connection.

“We were able to localize most of the capsule stimulations to the gastroduodenal segments of the digestive tract using abdominal X-ray imaging,” said Dr. Sahib Khalsa, a psychiatrist and neuroscientist at LIBR, and senior author of the study. “This finding is crucial as it provides a more precise understanding of where these gut-brain interactions are originating.”

“The potential clinical implications for the results of this study are substantial,” added Dr. Khalsa. “The vibrating capsule method could transform the clinical approach to disorders of gut-brain interaction, including eating disorders and certain gastrointestinal disorders such as irritable bowel syndrome (IBS) or functional dyspepsia.”

Related Links:
LIBR 
Vibrant Ltd. 


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Sling
GoComfort
New
Critical Care Cart
Avalo
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.